TABLE B-1 Adverse Events Included in the Vaccine Chapters
Adverse Event | MMR Vaccine Chapter 4 | Varicella Vaccine Chapter 5 | Influenza Vaccine Chapter 6 | Hepatitis A Vaccine Chapter 7 | Hepatitis B Vaccine Chapter 8 | HPV Vaccine Chapter 9 | DT–, TT–, and aP–Containing Vaccines Chapter 10 | Meningococcal Vaccine Chapter 11 | Injected-Related Events Chapter 12 |
Disseminated Oka VZV without Other Organ Involvement |
● |
||||||||
Disseminated Oka VZV with Subsequent Infection Resulting in Pneumonia, Meningitis, or Hepatitis |
● |
||||||||
Vaccine Strain Viral Reactivation without Other Organ Involvement |
● |
||||||||
Vaccine Strain Viral Reactivation with Subsequent Infection Resulting in Meningitis or Encephalitis |
● |
||||||||
Measles Inclusion Body Encephalitis |
● |
||||||||
Encephalitis |
● |
● |
● |
● |
● |
||||
Encephalopathy |
● |
● |
● |
● |
● |
● |
|||
Infantile Spasms |
● |
||||||||
Seizures |
● |
● |
❍ |
● |
● |
Meningitis |
❍ |
● |
|||||||
Cerebellar Ataxia |
● |
||||||||
Ataxia |
● |
● |
|||||||
Autism |
● |
● |
|||||||
Acute Disseminated Encephalomyelitis |
● |
● |
● |
● |
● |
● |
● |
||
Transverse Myelitis |
● |
● |
● |
● |
● |
● |
● |
||
Optic Neuritis |
❍ |
❍ |
❍ |
❍ |
|||||
Neuromyelitis Optica |
❍ |
● |
● |
||||||
Multiple Sclerosis |
● |
● |
● |
● |
● |
● |
|||
First Demyelinating Event |
● |
||||||||
Guillain-Barré Syndrome |
● |
● |
● |
● |
● |
● |
● |
||
Chronic Inflammatory Disseminated Polyneuropathy |
● |
● |
● |
● |
● |
● |
|||
Opsoclonus Myoclonus Syndrome |
● |
● |
|||||||
Bell’s Palsy |
● |
● |
● |
||||||
Brachial Neuritis |
● |
● |
● |
● |
|||||
Amyotrophic Lateral Sclerosis |
● |
||||||||
Small Fiber Neuropathy |
❍ |
● |
Adverse Event | MMR Vaccine Chapter 4 | Varicella Vaccine Chapter 5 | Influenza Vaccine Chapter 6 | Hepatitis A Vaccine Chapter 7 | Hepatitis B Vaccine Chapter 8 | HPV Vaccine Chapter 9 | DT–, TT–, and aP–Containing Vaccines Chapter 10 | Meningococcal Vaccine Chapter 11 | Injected-Related Events Chapter 12 |
Anaphylaxis |
● |
● |
● |
● |
● |
● |
● |
● |
|
Chronic Urticaria |
● |
||||||||
Serum Sickness |
● |
||||||||
Asthma |
● |
||||||||
Erythema Nodosum |
❍ |
||||||||
Systemic Lupus Erythematous |
● |
||||||||
Vasculitis |
● |
||||||||
Polyarteritis Nodosa |
● |
||||||||
Psoriatic Arthritis | |||||||||
Reactive Arthritis |
● |
||||||||
Rheumatoid Arthritis |
● |
||||||||
Juvenile Idiopathic Arthritis |
● |
||||||||
Arthropathy (Arthralgia and Arthritis) |
● |
● |
● |
● |
● |
||||
Type 1 Diabetes |
● |
● |
● |
||||||
Hepatitis (Autoimmune) |
● |
Myocarditis |
● |
||||||||
Pancreatitis |
● |
||||||||
Hepatitis |
● |
||||||||
Thromboembolic Events |
● |
||||||||
Stroke |
❍ |
● |
|||||||
Hypercoagulable States |
● |
||||||||
Myocardial Infarction |
● |
||||||||
Chronic Fatigue Syndrome |
● |
||||||||
Chronic Headaches |
● |
||||||||
Fibromyalgia |
● |
● |
● |
● |
|||||
Sudden Infant Death Syndrome |
● |
||||||||
Hearing Loss |
● |
||||||||
All-Cause Mortality |
❍ |
||||||||
Oculorespiratory Syndrome |
● |
||||||||
Thrombocytopenia |
● |
||||||||
Immune Thrombocytopenic Purpura |
● |
||||||||
Complex Regional Pain Syndrome |
● |
||||||||
Deltoid Bursitis |
● |
||||||||
Syncope |
● |
||||||||
NOTE: Adverse events indicated by “❍” were added to the list by the committee.